Disease block
D55-D59 – Hämolytische Anämien
- Chapter III: Krankheiten des Blutes und der blutbildenden Organe sowie bestimmte Störungen mit Beteiligung des Immunsystems
14Decisions
18Patient groups
Added benefit by patient group
- Minor2
- Non-quantifiable6
- Not proven10
Diseases in this disease block
- D56 Thalassämie 3 decisions
- D57 Sichelzellenkrankheiten 2 decisions
- D59 Erworbene hämolytische Anämien 9 decisions
Decisions, newest first
Each decision lists only the patient groups coded with a disease in this disease block.
- 2026-06-04FabhaltaIptacopanNot proven: 2 of 2 patient groups
- 2025-07-03CasgevyExagamglogen autotemcelNon-quantifiable
- 2025-07-03CasgevyExagamglogen autotemcelNon-quantifiable
- 2025-03-06PiaSkyCrovalimabNot proven: 2 of 2 patient groups
- 2024-11-22VoydeyaDanicopanNon-quantifiable
- 2024-11-22AspaveliPegcetacoplanNon-quantifiable
- 2023-11-02ReblozylLuspaterceptNot proven
- 2023-09-21ReblozylLuspaterceptMinor
- 2023-06-15EnjaymoSutimlimabMinor
- 2022-11-03OxbrytaVoxelotorNon-quantifiable
- 2022-09-15AspaveliPegcetacoplanNon-quantifiable
- 2022-03-18UltomirisRavulizumabNot proven: 2 of 2 patient groups
- 2021-01-21UltomirisRavulizumabNot proven
- 2020-02-06UltomirisRavulizumabNot proven: 2 of 2 patient groups
Data status: 2026-10-29